KR

Karen Russo

Vice President at ADC Therapeutics

Karen Russo is a seasoned pharmaceutical executive with extensive experience in leadership roles across various organizations. Currently serving as Vice President and Global Program Head at ADC Therapeutics since December 2022, Russo previously held key positions at Vertex Pharmaceuticals, Novartis, and Pfizer. Notable roles at Novartis include Vice President and Global Disease Lead for Benign Hematology, as well as multiple director and executive positions in CAR-T marketing. Russo's career began in sales with Pfizer, showcasing a progressive trajectory through marketing and leadership. Russo holds a Bachelor of Arts in Psychology from Clemson University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ADC Therapeutics

2 followers

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.


Industries

Employees

201-500

Links